SCHEMBL22908487

SCHEMBL22908487

COC(=O)NC(=S)Nc1ncccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
HPGD P15428 2/20 0.53
LMNA P02545 1/20 0.53
ALOX15 P16050 1/20 0.53
HSD17B10 Q99714 1/20 0.53
RAB9A P51151 7/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
MAPT P10636 4/20 0.48
NPC1 O15118 4/20 0.48
ALOX12 P18054 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HTT P42858 1/20 0.45
POLB P06746 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22151008 0.87 RAB9A (0.53) ALDH1A1LMNARAB9ASMN1; SMN2MAPT
SCHEMBL22908698 0.83 ALDH1A1 (0.53) ALDH1A1HPGDLMNAALOX15HSD17B10
SCHEMBL13963591 0.76 MAPT (0.44) ALDH1A1LMNARAB9ASMN1; SMN2MAPT
SCHEMBL7156184 0.75 MAPT (0.64) ALDH1A1LMNARAB9ASMN1; SMN2MAPT
SCHEMBL13170017 0.75 RAB9A (0.54) ALDH1A1LMNARAB9ASMN1; SMN2NPC1
SCHEMBL30511949 0.74 RAB9A (0.50) ALDH1A1LMNARAB9ASMN1; SMN2NPC1
SCHEMBL5467365 0.74 RAB9A (0.50) ALDH1A1LMNARAB9ASMN1; SMN2NPC1
SCHEMBL15348827 0.73 MEN1 (0.55) ALDH1A1LMNARAB9ASMN1; SMN2MAPT
SCHEMBL10867778 0.72 LMNA (0.67) ALDH1A1HPGDLMNAALOX15HSD17B10
SCHEMBL2634411 0.72 RAB9A (0.63) ALDH1A1LMNARAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339161-B2 Triazolo pyridines as modulators of gamma-secretase BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-24 US disclosed
EP-3672971-B1 TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE BOEHRINGER INGELHEIM INT (DE) 2021-07-14 EP disclosed
US-20210017173-A1 TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210017173-A1 TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE BACE1, BACE2, APP ALDH1A1 2894/4885HPGD 1127/4885LMNA 2702/4885
US-11339161-B2 Triazolo pyridines as modulators of gamma-secretase BACE1, BACE2, APP ALDH1A1 2894/4885HPGD 1127/4885LMNA 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.